NewsVandana Singh
Verve Therapeutics
VERV · NASDAQ
Price unavailable right now.
No price history for this range.
Latest news
- Press releasePRNewswire
Lilly completes acquisition of Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk
- Press releasePRNewswire
Lilly and Verve announce expiration of Verve tender offer
- Press releasePRNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VERV, CTLP, SAGE on Behalf of Shareholders
- Press releasePRNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VERV, SAGE, CTLP, COLB on Behalf of Shareholders
- Press releaseBusiness Wire
VERVE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Verve Therapeutics, Inc. - VERV
- NewsVandana Singh
Eli Lilly's $1.3 Billion Verve Deal Signals Confidence In Gene Editing Space: Analyst
- News
5 Analysts Assess Verve Therapeutics: What You Need To Know
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- Press releaseBusiness Wire
VERV Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Verve Therapeutics, Inc. Is Fair to Shareholders
- NewsAvi Kapoor
Top 3 Health Care Stocks That Are Ticking Portfolio Bombs
- Press releaseBusiness Wire
Shareholder Alert: The Ademi Firm Investigates Whether Verve Therapeutics, Inc. Is Obtaining a Fair Price for Its Public Shareholders
- NewsVandana Singh
Eli Lilly Expands Into Gene Editing With Verve Therapeutics Acquisition
- Press releasePRNewswire
Lilly to acquire Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk
- NewsAvi Kapoor
Why Lennar Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
- Press releaseGlobe Newswire
Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2025 Financial Results
- NewsAvi Kapoor
Wolverine World Wide, Pacira BioSciences And Other Big Stocks Moving Higher On Monday
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- News
Assessing Verve Therapeutics: Insights From 4 Financial Analysts
- NewsVandana Singh
Verve Therapeutics Touts Positive Data From Gene Editing Medicine To Lower Cholesterol After Single Dose
- Press releaseGlobe Newswire
Verve Therapeutics Announces Positive Initial Data from the Heart-2 Phase 1b Clinical Trial of VERVE-102, an In Vivo Base Editing Medicine Targeting PCSK9
- Press releaseGlobe Newswire
Verve Therapeutics Receives U.S. FDA Fast Track Designation for VERVE-102, an In Vivo Base Editing Medicine Targeting PCSK9
- Press releaseGlobe Newswire
Climb Bio Appoints Seasoned Biotech Leaders to Board of Directors
- Press releasePRNewswire
Kuehn Law Encourages Investors of Verve Therapeutics, Inc. to Contact Law Firm
- News
Analyst Scoreboard: 4 Ratings For Verve Therapeutics
- Press releasePRNewswire
VERV Investors Have Opportunity to Lead Verve Therapeutics, Inc. Securities Fraud Lawsuit Filed by the Schall Law Firm
- Press releasePRNewswire
Verve Therapeutics Inc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - VERV
- Press releasePRNewswire
Verve Therapeutics, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before October 28, 2024 to Discuss Your Rights - VERV
- Press releaseBusiness Wire
VERV Deadline: Rosen Law Firm Encourages Verve Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 28 Deadline in Securities Class Action Commenced by the Firm – VERV
- Press releasePRNewswire
VERV Investors Have Opportunity to Lead Verve Therapeutics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm
- Press releasePRNewswire
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Verve Therapeutics, Inc. - VERV
- Press releasePRNewswire
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Verve Therapeutics
- Press releasePRNewswire
Verve Therapeutics Inc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - VERV
- Press releasePRNewswire
Investors who lost money on Verve Therapeutics, Inc.(VERV) should contact Levi & Korsinsky about pending Class Action - VERV
- Press releaseGlobe Newswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against WEBTOON, Verve, Domino's, and iLearningEngines and Encourages Investors to Contact the Firm
- Press releasePRNewswire
VERV Deadline: VERV Investors Have Opportunity to Lead Verve Therapeutics, Inc. Securities Fraud Lawsuit
- Press releasePRNewswire
VERV Investors Have Opportunity to Lead Verve Therapeutics, Inc. Securities Fraud Lawsuit Filed by the Schall Law Firm
- Press releasePRNewswire
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Verve Therapeutics, Inc. - VERV
- Press releaseGlobe Newswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against WEBTOON, Verve, Domino's, and Ardelyx and Encourages Investors to Contact the Firm
- Press releaseGlobe Newswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against WEBTOON, Verve, Domino's, and Ardelyx and Encourages Investors to Contact the Firm
- Press releaseGlobe Newswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against WEBTOON, Verve, Domino's, and Ardelyx and Encourages Investors to Contact the Firm
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.